ID: ALA4877822

Max Phase: Preclinical

Molecular Formula: C13H13N3O2

Molecular Weight: 243.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1c(C)nc2n(C)c3ccccc3n12

Standard InChI:  InChI=1S/C13H13N3O2/c1-8-11(12(17)18-3)16-10-7-5-4-6-9(10)15(2)13(16)14-8/h4-7H,1-3H3

Standard InChI Key:  YXZFPFVRPAIWBT-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.27Molecular Weight (Monoisotopic): 243.1008AlogP: 1.92#Rotatable Bonds: 1
Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.46CX LogP: 1.34CX LogD: 1.34
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.61Np Likeness Score: -1.15

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source